Company

AuXin Surgery was incorporated in Belgium in January 2014 as a limited liability company. The Company is the pioneer of devices for chemically assisted dissection (CADISS® Method) in surgery.

The objective is to make available to surgeons this novel method for use in many surgical procedures. The Company develops and sells complete CADISS® systems for targeted applications..

AuXin Surgery is ISO 13485 (2016) certified.

Management Team

DELCORPS Xavier

CHIEF COMMERCIAL OFFICER

x

VERJANS Benoît

CHIEF EXECUTIVE OFFICER

x

FERRIERE Laurent

CHIEF TECHNOLOGY OFFICER

QA/RA DIRECTOR

 

x

GORDENNE Valérie

CHIEF SCIENTIFIC OFFICER

x

Shareholders

Gilles Capart & Family

Business Angels

Angels.be

Collaborations

Scientific

Industrial

Belgian funding

European funding

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 882323.

News & Events

Congresses / Expert presentation – CADISS®

All
Congresses
Seminars
Next AuXin congresses
Distributor congresses
Press
Déc
03
2020

Healthcare Expo | Taiwan

CongressesNext Congresses
Oct
30
2020

ONLINE ID SPINE 2020 | Spine Society Belgium

Congresses
Oct
28
2020

Medlab | Bangkok

Congresses
Août
18
2020

SURGICAL INNOVATION COULD MAKE OPERATIONS SAFER

Press
Juin
16
2020

AUXIN SURGERY SEDUIT DE PLUS EN PLUS DE CHIRURGIENS DANS LE MONDE

Press
Mai
19
2020

Hospitalar | São Paulo

CongressesNext Congresses
Mai
08
2020

Inter Disciplinary Spine Brussels 2020 | Brussels

CongressesNext Congresses
Jan
30
2020

22e Assises d’ORL | Nice

Congresses
Jan
27
2020

Arabhealth | Dubai

Congresses
Nov
29
2019

German distributor Vostra | DWG Kongress | Munich

Congresses

Careers